As one of the fastest Multi specialty site, Agile CRT is right where you need us with the global experience, infrastructure, knowledge, and technology to conduct clinical trials and observational research programs of any size.
Whatever the size of your study, we can plan and conduct your trial from beginning to end. Agile Clinical Research Trails is a Global Clinical Research Originations sites are in Asia, Central America and South America and North America. ACRT adopt six-sigma methodology to improve clinical quality and outcomes.
Cardiovascular – Specialized recruitment strategies and safety monitoring for large cardiovascular outcomes trials, as well as strategic expertise in rapid market access through niche indications like homozygous familial hypercholesterolemia
Central Nervous System (CNS) – Hands-on expertise for pain, neurology and psychiatry indications
Endocrinology – Covering the spectrum from diabetes & obesity to rare genetic metabolic and growth disorders
Gastroenterology – A dedicated team with a deep understanding of the broad digestive disorders spectrum and close relationships with gastroenterologists, physicians, investigators and Key Opinion Leaders across the globe
Pain – Experience using a wide variety of models to minimize placebo effects and maximize the chance for success
Psychiatry – Connections to academic and private practice expert investigators and an understanding of how to manage the many external factors that can effect outcomes
Respiratory – Experience in asthma, COPD, cystic fibrosis, respiratory infections, pulmonary arterial hypertension and smoking cessation
Women's Health – An appreciation of gender differences not only as they affect disease incidence, but in ways that can enhance recruitment and retention of female patients
Our expertise can make a significant difference in successful protocol completion. With our therapeutic clinical trial experience and the depth of our clinical trials services, Agile CRT is the leading therapeutic clinical research organization in Phase I - Phase IV trials.
Please Contact Us for further information...